학술논문
Cutting edge biomarkers strategy to provide early insights into activity of EVT-801, a novel selective VEGFR-3 inhibitor that targets tumor angiogenesis during the FIH clinical trial.
Document Type
Journal
Author
Paillasse, Michael R.; Garner, James; Fitzgerald, Michael; Davenne, Lise; Ancey, Pierre-Benoit; Poussereau-Pomie, Celine; Esquerre, Michael; Badet, Gaelle; Tuyaret, Joel; Mandron, Marie; Rochaix, Philippe; Ayyoub, Maha; Scarlata, Clara Maria; Menetrier-Caux, Christine; Caux, Chrsitophe; Cassier, Philippe; Delord, Jean-Pierre; Roca, Carlos Gomez; Fons, Pierre
Source
Subject
Language
English
ISSN
15387445